Milan biotech Aptadir Therapeutics raises €40 million seed round
Aptadir Therapeutics Issuer · 4BIO Capital Lead investor · EXTEND Investor
Aptadir Therapeutics Issuer · 4BIO Capital Lead investor · EXTEND Investor
Intelligence
As of this development: a later development may record new terms.
Activity